Polymorphisms in CYP2D6 may predict methamphetamine related heart failure

The Relationship Between Methamphetamine Use and Increased Dental Disease

(2014) Vivek Shetty et al.   JOURNAL OF THE AMERICAN DENTAL ASSOCIATION

The unique histology of methamphetamine cardiomyopathy: A case report

(2011) Steven B. Karch   FORENSIC SCIENCE INTERNATIONAL

Genomics, Health Care, and Society

(2011) Kathy L. Hudson   NEW ENGLAND JOURNAL OF MEDICINE

Health outcomes associated with methamphetamine use among young people: a systematic review

(2010) Brandon D. L. Marshall et al.   ADDICTION

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: Preliminary findings

(2010) MARIANA CHERNER et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Pharmacogenomics instruction in US and Canadian medical schools: implications for personalized medicine

(2010) James S Green et al.   PHARMACOGENOMICS

Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants

(2010) Andrea Gaedigk et al.   Frontiers in Pharmacology

Stereoselectivity in the human metabolism of methamphetamine

(2009) Linghui Li et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A Comparison of Echocardiographic Findings in Young Adults With Cardiomyopathy: With and Without a History of Methamphetamine Abuse

(2009) Hiroki Ito et al.   CLINICAL CARDIOLOGY

Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults

(2009) Mariana Cherner et al.   DRUG AND ALCOHOL DEPENDENCE

Illicit Stimulant Use in a United States Heart Failure Population Presenting to the Emergency Department (from the Acute Decompensated Heart Failure National Registry Emergency Module)

(2008) Deborah B. Diercks et al.   AMERICAN JOURNAL OF CARDIOLOGY